Frontlight ResearchEarly access
CompletedNo phase
Evaluation of Eye Health Benefits of Black Tomato Extract
Key facts
- Who runs it
- TCI Co., Ltd.
- Where
- Taiwan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 56 people enrolled
- Started
- 1 Apr 2024
- Ended
- 30 Apr 2025
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Black tomato extract powder
- Placebo powder
- Record updated
- 13 June 2025
Who can take part
- Age
- 20 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Age greater than 20 and capable of providing informed consent
- Daily usage of 3C (computer, communication, and consumer electronics) for more than 6 hours (OSDI screening - those experiencing dryness and fatigue in the eyes)
- BMI between 22 and 35
- High myopia population (-5.00 to -9.00D)
Who cannot take part
- Long-term use of medications affecting the anterior surface of the eye
- History of any eye surgery (e.g., strabismus surgery, refractive surgery)
- Presence of systemic diseases affecting the anterior surface of the eye
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Verification of the efficacy of black tomato extract for eye health.
The 2 groups in the trial
- Placebo powderPlacebo, for comparison
Dietary Supplement: Placebo powder
- Black tomato extract powderTreatment being tested
Dietary Supplement: Black tomato extract powder
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 13 June 2025